Data category | Information |
Primary registry and trial identifying number | Australian New Zealand Clinical Trials Registry (https://www.anzctr.org.au) Ref No. ACTRN12617000251325 |
Date of registration | 17 February 2017 |
Public title | Comparing Home Infusion Devices for antibiotic treatment—CHID Study |
Scientific title | A randomised crossover trial evaluating patient and nurse satisfaction of the electronic portable infusion device (ambIT Continuous) versus elastomeric delivery (Baxter Infusor) for the continuous administration of antibiotics in the home in patients with infectious disease |
Trial acronym | CHID |
Health conditions | Any infectious disease requiring intravenous antibiotic therapy and suitable for treatment via a continuous infusion in the home setting |
Study type | Interventional |
Intervention code | Treatment: devices |
Control treatment | Treatment administered via an elastomeric infusion pump |
Key inclusion criteria | Suitable for ambulatory home antibiotic therapy as approved by infectious diseases specialist Inpatient of Royal Adelaide Hospital Can provide informed consent Require 8 days minimum therapy Able to provide feedback through questionnaire and logbook 18 years of age or older |
Key exclusion criteria | Patient is unable or unwilling to fill out the patient questionnaire survey and or logbook Skin allergy or contact dermatitis to stainless steel Patient's primary clinician is unwilling to enrol patient Pregnancy Patient is totally dependent on care for all daily needs and/or is immobile The following antibiotics are excluded due to restricted shelf life: ceftazidime, ticarcillin/clavulanate |
Recruitment state | South Australia |
Recruitment hospital | The Royal Adelaide Hospital—Adelaide |
Funding source 1 | Government of South Australia, Department of Further Education, Employment, Science and Technology (now Department of State Development) |
Funding source 2 | CPIE Pharmacy Services, Findon, South Australia |
Primary sponsor | Flinders University, Bedford Park, South Australia |
Other collaborator | CPIE Pharmacy Services, Findon, South Australia |
Ethics committee | Royal Adelaide Hospital Human Research Ethics Committee, Approval No. R20160420 |